Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023 Full year revenues increased 473% to $290.5 million versus 2023 CFF TDN granted full sanctioning of KB407 Phase ...

PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today reported financial results for the fourth quarter ...

Cataracts, dry eyes, glaucoma and other eye problems become more common with age. But these can be treated — and sometimes ...

Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...

Use corneal diagnostic tools to pick the right candidates. KOLOA, Hawaii — Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according ...

A small peripheral corneal melt in an 8-mm-diameter-plus LASIK flap is not visually significant, whereas overly aggressive treatment can result in a serious sight-threatening course of serial ...

The firm is commercializing and developing treatments for various diseases of the cornea. Its potential market size is rather small, but the company has little apparent direct competition and has ...

The Royal Devon and Exeter Hospital (RD&E) has become the first NHS hospital in the south-west of England to perform an artificial cornea transplant, managers say. Jason Maddocks, 54, was the ...

igmtl.com Aims To determine the influence of prostaglandin analogues (PGAs) on corneal biomechanical properties in patients undergoing chronic treatment for primary open-angle glaucoma (POAG). Results ...

The currently used treatment parameters are set so as to treat the anterior 250–350 µm of corneal stroma, thus preventing damage to the corneal endothelium. The stiffening effect is ...